Active, Not Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
NCT05544552
- Conditions
- Advanced Solid Tumor, Advanced Urothelial Carcinoma, Bladder Cancer, +31 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- UMass Memorial Medical Center Worchester, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
- Duke Cancer Institute (DCI) - Duke Cancer Center Durham, North Carolina, United States